Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Mechanical stress contributes to hair loss in androgenetic alopecia.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Trichoscopy helps tell apart hair loss due to alopecia areata from trichotillomania in eyebrows.

Severe itching from shingles can cause hair loss due to rubbing.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Adults with alopecia areata often have empty follicular openings, while children show more honeycomb pigment patterns.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Lichen planopilaris should be considered in diagnosing scarring hair loss in Black women.

Oral tofacitinib successfully treated total body hair loss in one patient.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.